Luvox CR Symptom Benefit Claims Draw DDMAC Warning
Executive Summary
An FDA warning letter to Jazz Pharmaceuticals citing a Luvox CR (fluvoxamine maleate) patient brochure continues an agency trend of targeting efficacy claims about individual symptoms of a broader disease state